跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维思通 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Risperidone Oral Solution
Approved
化学药品
Risperidone Oral Solution
Janssen-Cilag NV
🇨🇳 National Medical Products Administration
Approval Date
Nov 16, 2022
Approval ID
89c18f180518b22c
Company
Janssen-Cilag NV
Type
化学药品
Approval Details
Approval Id
89c18f180518b22c
Approval Number
国药准字HJ20171343
Generic Name
利培酮口服液
Generic Name En
Risperidone Oral Solution
Trade Name
维思通
Drug Type
化学药品
Dosage Form
口服溶液剂
Strength
(1)0.1% (30ml:30mg) (2)0.1% (100ml:100mg)
Reg Date
2022-11-16
Expired Date
2027-11-15
Company Name
Janssen-Cilag NV
Company Detail Path
/organization/janssen-cilag-nv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 16, 2022
Approval ID
89c18f180518b22c
Type
化学药品
Back to NMPA Approvals